Used in biomedical research to quantify CDK1 protein levels in cell lysates or tissue samples. Helps study cell cycle regulation, particularly the G2 to M phase transition. Applied in cancer research to assess CDK1 activity in tumor cells, evaluate responses to chemotherapeutic agents, and investigate mechanisms of cell proliferation. Also utilized in drug development to screen compounds that modulate CDK1 expression or activity. Supports research in cellular signaling, apoptosis, and DNA damage response pathways.